The DOI matches its Crossref record; 405 of the 406 references it cites were found in a registry or an index.
Reduced Vancomycin Susceptibility in Staphylococcus aureus , Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications
Open accessAbstract
SUMMARY: The emergence of vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) over the past decade has provided a challenge to diagnostic microbiologists to detect these strains, clinicians treating patients with infections due to these strains, and researchers attempting to understand the resistance mechanisms. Recent data show that these strains have been detected globally and in many cases are associated with glycopeptide treatment failure; however, more rigorous clinical studies are required to clearly define the contribution of hVISA to glycopeptide treatment outcomes. It is now becoming clear that sequential point mutations in key global regulatory genes contribute to the hVISA and VISA phenotypes, which are associated predominately with cell wall thickening and restricted vancomycin access to its site of activity in the division septum; however, the phenotypic features of these strains can vary because the mutations leading to resistance can vary. Interestingly, changes in the staphylococcal surface and expression of agr are likely to impact host-pathogen interactions in hVISA and VISA infections. Given the subtleties of vancomycin susceptibility testing against S. aureus , it is imperative that diagnostic laboratories use well-standardized methods and have a framework for detecting reduced vancomycin susceptibility in S. aureus .
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Due to the difficulties on detecting these strains, vancomycin failures have been increasingly reported in deep-seated infections.”
From Mechanisms of Antibiotic Resistance (2016) · cites this paper as [101]
In the citing paper
“Indeed, S. aureus within the range of susceptibility, with vancomycin MICs > 1 and ≤ 2 μg/ml have been more frequently associated with the hVISA phenotype.”
From Mechanisms of Antibiotic Resistance (2016) · cites this paper as [101]
In the citing paper
“These global homeostatic changes appear to lead to a reduced autolytic activity with thickened cell wall and an increase amount of free D-Ala-D-Ala dipeptides with less peptidoglycan cross-linking (101, 104).”
From Mechanisms of Antibiotic Resistance (2016) · cites this paper as [101]
In the citing paper
“Phenotypically, hVISA/VISA strains exhibit distinct metabolic characteristics that may include i) increase in fructose utilization, ii) increased fatty acid metabolism, iii) impaired acetate metabolism and tricarboxylic acid cycle, iv) decrease in glutamate availability, and iv) increase expression of cell wall synthesis genes.”
From Mechanisms of Antibiotic Resistance (2016) · cites this paper as [101]
In the citing paper
“As the “resistant” subpopulation is difficult to identify, detection of hVISA becomes very challenging and some S. aureus strains reported as “susceptible” to vancomycin by standard susceptibility testing may still exhibit this phenotype (101).”
From Mechanisms of Antibiotic Resistance (2016) · cites this paper as [101]
In the citing paper
“In addition, VISA strains bind vancomycin more avidly than their non –VISA counterparts, however, diffusion of the antibiotic molecule into the inner part of the cell wall appears to be impaired.”
From Mechanisms of Antibiotic Resistance (2016) · cites this paper as [101]
In the citing paper
“Finally, a striking feature of many hVISA/VISA strains is the ability to revert from one phenotype to another (or even to a fully vancomycin susceptible phenotype) in the absence of vancomycin exposure.”
From Mechanisms of Antibiotic Resistance (2016) · cites this paper as [101]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
Staphylococcus aureus Infections
Lowy, F. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808203390806 · Cited by 6,018
Klevens, R. M. (2007) · JAMA · doi:10.1001/jama.298.15.1763 · Cited by 3,726
Lew, D. P., & Waldvogel, F. A. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16727-5 · Cited by 1,988
Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility
Hiramatsu, K. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.1.135 · Cited by 1,984
Vandenesch, F., Naimi, T. S., Enright, M. C., Lina, G., Nimmo, G. R., Heffernan, H., Liassine, N., Bes, M., Greenland, T., Reverdy, M. E., et al. (2003) · Emerging infectious diseases · doi:10.3201/eid0908.030089 · Cited by 1,718
Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by Staphylococcus aureus
Fowler, V. G., Boucher, H. W., Corey, G. R., Abrutyn, E., Karchmer, A. W., Rupp, M. E., Levine, D. P., Chambers, H. F., Tally, F. P., Vigliani, G. A., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053783 · Cited by 1,459
The Changing Epidemiology of Staphylococcus aureus ?
Chambers, H. F. “. (2001) · Emerging infectious diseases · doi:10.3201/eid0702.010204 · Cited by 1,419
Plasmid-Mediated Resistance to Vancomycin and Teicoplanin in Enterococcus Faecium
Leclercq, R., Derlot, E., Duval, J., & Courvalin, P. M. (1988) · New England Journal of Medicine · doi:10.1056/nejm198807213190307 · Cited by 1,411
Diekema, D. J., Pfaller, M. A., Schmitz, F., Smayevsky, J., Bell, J. M., Jones, R. N., Beach, M. L., & SENTRY Participants Group (2001) · Clinical Infectious Diseases · doi:10.1086/320184 · Cited by 1,363
Research works printed but not linked: 1
- Ferraz, V., A. G. Duse, M. Kassel, A. D. Black, T. Ito, and K. Hiramatsu. 2000. Vancomycin-resistant Staphylococcus aureus occurs in South Africa. S. Afr. Med. J.90:1113.
Cited by
Sorted by citations
Items 901–962 of 962
Mediati, D. G., Dan, W., Lalaouna, D., Dinh, H., Pokhrel, A., Stinear, T. P., Cain, A. K., & Tree, J. J. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.16.541063
Self-citationHeckler, E. P., Ali, L., Bhattarai, S., Cagle-White, B., Smith, N., Coover, R. A., Aziz, M. H. A., & Sarkar, A. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.31.555806
Study of susceptibility to vancomycin from clinical isolates of Staphylococcus aureus
Sosa, L., Enríquez, L., Rojas, N., & Espinoza, L. C. (2023) · Bionatura · doi:10.21931/rb/2023.08.03.35
Velusamy, S., Abuthakir, M. H. S., Khan, J. M., Ahmad, A., & Jeyam, M. (2023) · Journal of King Saud University - Science · doi:10.1016/j.jksus.2023.102917
Hira, J., Singh, B., Halder, T., Mahmutovic, A., Ajayi, C., Sekh, A. A., Hegstad, K., Johannessen, M., & Lentz, C. S. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.02.562170
Pethakamsetty, L., Pola, S., & Giduthuri, J. G. (2023) · Springer eBooks · doi:10.1007/978-981-99-5114-7_13
Prasetyoputri, A., Warsito, M. F., Atikana, A., Putro, E. W., Kholida, L. N., & Sukmarini, L. (2023) · AIP conference proceedings · doi:10.1063/5.0185419
Characteristics of Laboratory-Derived Vancomycin-Intermediate Staphylococcus aureus Strains
Jongutsa, S., Trakulsomboon, S., Pannanusorn, S., Chanklan, R., Chantorn, S. T., Surarit, W., Traijitt, T., & Utaida, S. (2024) · Journal of Current Science and Technology · doi:10.59796/jcst.v14n2.2024.21
Zhuo, Y., Chen, P., Zhou, Z., Chen, R., Yu, N., Jiang, Y., Cheng, S., Cai, J., Zhang, Y., & Wang, X. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.155216
Al-Hayali, O. Z., Marjani, M. F. A., & Maleki, A. (2024) · IRAQI JOURNAL OF AGRICULTURAL SCIENCES · doi:10.36103/hwm37e61
Phenotypic variations of staphylococcal pathogenesis: a comprehensive review
Ghazaei, C., & Khalid, L. (2024) · Reviews in Medical Microbiology · doi:10.1097/mrm.0000000000000395
Staphylococcus , Micrococcus , and Other Catalase‐Positive Cocci
Becker, K., David, M. Z., & Skov, R. L. (2023) · ClinMicroNow · doi:10.1002/9781683674849.mcm0021
Prasetyoputri, A., Pitt, M. E., Cao, M. D., Ramu, S., Kavanagh, A. M., Elliott, A. G., Ganesamoorthy, D., Monk, I. R., Stinear, T. P., Cooper, M. A., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.22.630013
Self-citationZhu, F., Sun, L., Chen, Y., Wang, Z., Hong, Y., Jiang, S., Zhuang, H., Wang, H., Yu, Y., & Chen, Y. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5087393
Special Phenotypic Methods for Detecting Antibacterial Resistance
Simner, P. J., & Humphries, R. M. (2023) · ClinMicroNow · doi:10.1002/9781683670438.mcm0076
Alotaibi, A., AlShehri, L. M., Ashqar, A. A., Almarwan, S. R., Kuwaity, L. H., Alamoudi, A. O., & Aref, M. (2025) · World Neurosurgery · doi:10.1016/j.wneu.2025.124220
Vedeneev, P. A., Buhler, A., Lebedeva, I. A., & Kovaleva, E. G. (2025) · Siberian Journal of Life Sciences and Agriculture · doi:10.12731/2658-6649-2025-17-3-1131 · Cited by 1
Host-adaptive evolution of Staphylococcus aureus
Lowder, B. V. (2011) · ERA
Kang, Y. R., Kim, S.-H., Chung, D. R., Ko, J.-H., Huh, K., Cho, S. Y., Kang, C.-I., & Peck, K. R. (2022) · Figshare · doi:10.6084/m9.figshare.20444143
Cagle-White, B., Bhattarai, S., Sunderhaus, A., Scott, E., Solis, A., Marsh, L., Catague, K. L., Sarkar, A., & Aziz, M. H. A. (2025) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2025.110715
Alsharif, K. F., & Rahman, H. (2026) · Journal of Tropical Medicine · doi:10.1155/jotm/6640607
Repurposed bunamidine disrupts envelope energetics and induces ROS-mediated non-lytic killing
Huang, G., Guo, S., Xiao, D., Liu, Y., Li, M., Lu, L., Hong, Y., Li, Y., Zou, M., & Wu, Y. (2026) · AMB Express · doi:10.1186/s13568-026-02016-6
Yılmaz, Ö. T., & Hızlısoy, H. (2019) · DergiPark (Istanbul University)
Vancomycin-Resistant Clinical Strains of Enterococcus spp. and Staphylococcus aureus
Lebedkova, A. A., Khokhlova, O. E., Коломбет, Л. В., & Николаевич, К. Н. (2026) · Antibiot Khimioter = Antibiotics and Chemotherapy · doi:10.37489/0235-2990-2025-70-11-12-75-91
Chang, T., Li, F., Feng, C., Wang, X., & Guan, D. (2026) · ChemMedChem · doi:10.1002/cmdc.202501084
Sisodia, K., Panda, A., Haridas, H., Rynga, D., Kumar, D., & Gaind, R. (2026) · New Microbes and New Infections · doi:10.1016/j.nmni.2026.101742 · Cited by 1
Marenna, A. (2017) · theses.fr (ABES) · doi:10.70675/d2c20f17zb6ffz4e62zac0fzc1223641f6f8
Staphylococcus aureus Regulatory RNAs Driving Fitness upon Antibiotic Exposure
Liu, W. (2018) · theses.fr (ABES) · doi:10.70675/1ab43e4bz428bz410ez90c9z8b5f463c1e38
Cuenot, E. (2018) · theses.fr (ABES) · doi:10.70675/6c9844bcz95e7z48b9za811z2199772e1a95
da Luz, B. S. R. (2022) · theses.fr (ABES) · doi:10.70675/2e2fa4bfz4a44z4eb8za456z56828affa1d9
Khalili, H., Mahrooghi, M., Peerayeh, S. N., Alamdary, S. Z., Sepas, H. N., & Bakhshi, B. (2026) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/cjid/5695498
Mapping cancer drug resistance mutations and mechanisms
Vidwans, A., Ellis, L., Stauffer, P., Lai, R., Shamis, A., & Preuss, C. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-43870-7.00017-5
Nettleton, M. R., Shim, H. M., Abbotsford, J., Goff, Z., Hazelton, B. J., O'Brien, M. P., Porter, T., Snelling, T., Yeoh, D. K., Bowen, A. C., et al. (2026) · Journal of Pharmacy Practice and Research · doi:10.1002/jppr.70076
Li, G., El-Deeb, I. M., Whyte, H. G., Blaskovich, M. A. T., Walker, M. J., von Itzstein, M., & Oliveira, D. M. P. D. (2026) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkag186
Giuliano, S., Cojutti, P. G., Bulfoni, M., Cotrufo, M., Curcio, F., Gualandi, N., Lombardo, C., Moreal, C., Pea, F., Tascini, C., et al. (2026) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2026.107877
Yang, D., Gu, M., Tang, X., He, L., (48506), J. Z., Wang, X., Hou, Y., Cui, Y., Li, C., Tian, J., et al. (2026) · BMC Infectious Diseases · doi:10.1186/s12879-026-13473-6
Sahu, M., Narwal, N., Vinchurkar, R. V., Sangam, S., Srinivasan, J., Parachalil, K., Vishweswaraiah, R. H., & Pradhan, D. (2026) · Microbial Pathogenesis · doi:10.1016/j.micpath.2026.108822
Li, C., Kong, F., Li, W., Li, B., & Xue, T. (2026) · Journal of Dairy Science · doi:10.3168/jds.2026-28839
Hou, J., Peng, C., Chen, W. Y., Peng, L., Yk, M., & Kang, M. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1723669 · Cited by 1
Molecular basis of antimicrobial resistance in ESKAPE pathogens
Ziko, L., & Hussein, N. A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-26726-0.00018-9
Fenniri, I., & André, C. (2026) · Antibiotics · doi:10.3390/antibiotics15070710
Xi, L., Bian, Q., Yang, P., Wu, H., Shi, X., Guo, B., Fan, Y., & Zhang, J. (2026) · Emerging Microbes & Infections · doi:10.1080/22221751.2026.2698241
Hoo, W. P. Y., Gullick, J., Leung, R. F., Fulcher, A. J., Cass, R. W., Tailhades, J., Peleg, A. Y., Payne, J. A. E., O’Keeffe, M. A., & Cryle, M. J. (2026) · ChemBioChem · doi:10.1002/cbic.70495
Idrees, A., Abbas, I. S., Li, J., Hussein, M., & Velkov, T. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1919407
Gonzalez, M., Ruiz, J., Torres, L., & Ruiz, E. (2025) · Annals of Pharmacy Practice and Pharmacotherapy · doi:10.51847/4ecoyn8z8x
Bîrluțiu, V., & Bîrluţiu, R. M. (2026) · Microorganisms · doi:10.3390/microorganisms14091951
Squitieri, D., Menchinelli, G., Rohde, H., Sanguinetti, M., & Posteraro, B. (2026) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2026.09.010
Zborowsky, S., Łapińska, U., O'Neill, P., Farbos, A., Jeffries, A. R., Ba, X., Holmes, M. A., Laabei, M., Zhang, B., Blaskovich, M. A. T., et al. (2026) · mSystems · doi:10.1128/msystems.00734-26
AI-driven nanostructured biosensor for triple-domain diagnostics
Paul, S., Singh, R., Dutta, D., Sadhu, S., & Mukherjee, S. (2026) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2026.07.012
Lusardi, M., Caviglia, D., Chiocca, A., Ponassi, M., Piatti, G., Salis, A., Spallarossa, A., Schito, A. M., & Brullo, C. (2026) · ACS Omega · doi:10.1021/acsomega.6c03582
Adejumo, A. E., Ikhimiukhor, O. O., Andam, C. P., & Adelowo, O. O. (2026) · Letters in Applied Microbiology · doi:10.1093/lambio/ovag085
Fan, Y., Xi, L., Yang, P., Wu, H., Li, N., Bian, Q., Zheng, H., Zhu, Y., Wu, J., Guo, B., et al. (2026) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2026.108021
Hong, Y., Zhuang, H., Wang, H., Guo, Y., Keren, S., Chen, Y., Zhu, F., Zhang, X., Hu, F., Sun, L., et al. (2026) · Drug Resistance Updates · doi:10.1016/j.drup.2026.101487
Pharmacodynamic evaluation of the novel vancomycin derivative LYSC98
Wang, X.-K., Li, X., Lu, F., Wang, P., Wu, H.-G., Ma, M.-Y., Hu, X.-X., Nie, T.-Y., Li, G.-Q., Li, C., et al. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.179465
Camargo, C. H. (2012) · Americanae (AECID Library)
Metadata
- Authors
- Howden, B. P., Davies, J. K., Johnson, P. D. R., Stinear, T. P., & Grayson, M. L.
- Affiliations
- The University of Melbourne (AU)
- Monash University (AU)
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2010-01
- Volume
- 23
- Issue
- 1
- Pages
- 99-139
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- PMC
- PMC2806658
- OpenAlex
- W2126915534
- Cited by
- 962
- References
- 406
- Citations by year
- 2026: 42 · 2025: 41 · 2024: 48 · 2023: 58 · 2022: 45 · 2021: 52 · 2020: 49 · 2019: 60 · 2018: 54 · 2017: 51 · 2016: 63 · 2015: 83 · 2014: 69 · 2013: 88 · 2012: 72
- FWCI
- 9.15
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Clinical Microbiology Reviews (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Keywords
- vancomycin-intermediate Staphylococcus aureus, heterogeneous vancomycin-intermediate Staphylococcus aureus, reduced vancomycin susceptibility, glycopeptide resistance, cell wall thickening, agr gene, vancomycin susceptibility testing, treatment failure, host-pathogen interaction
- MeSH terms
- Anti-Bacterial Agents, Humans, Microbial Sensitivity Tests, Staphylococcal Infections, Staphylococcus aureus, Vancomycin, Treatment Outcome, Vancomycin Resistance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
